In contrast, we found evidence that increasing parity was protective among both BRCA1 and BRCA2 mutation carriers, and that BRCA1 mutation carriers with two or more offspring had a significantly lower breast cancer risk. This evidence concerns the gene BRCA2 and breast cancer.